Authors
Min Jiang, Felix Sieber-Schäfer, Simone P. Carneiro, Dana Matzek, Anny Nguyen, Diana Leidy Porras-Gonzalez, Arun Kumar Verma, Miriam Kolog-Gulko, David C. Jürgens, Gerald Burgstaller, Bastian Popper, Xun Sun, and Olivia M. Merkel
Highlights
Fluc mRNA transfection efficiency in BMDCs after 24 and 48 h of incubation. FLuc mRNA was delivered by means of LNP (PLGA or PBAE) or Lipofectamine 2000.
Source: Adapted from Article under the CC BY 4.0 license. Visual design and formatting modified by RIBOPRO.
DOI
https://doi.org/10.1016/j.celbio.2025.100311
Journal: Cell Biomaterials
PMID: 41868473
Click here for link to full article
Summary:
Effective pulmonary messenger RNA (mRNA) vaccination requires delivery systems capable of overcoming the airway barrier and efficiently transfecting pulmonary antigen-presenting cells. Here, we developed a hybrid polymeric system incorporating poly(lactic-co-glycolic) acid (PLGA) and poly(β-amino esters) (PBAEs) to enhance pulmonary mRNA delivery. The components acted through a spatiotemporally coordinated cascade: early PLGA hydrolysis acidified endosomes, boosting PBAE protonation and tightening mRNA condensation for protection; increased buffering, driven by accelerated protonation, strengthened proton-sponge-mediated escape; and weakened electrostatic interactions in the cytosol enabled rapid mRNA release and translation in dendritic cells, supporting immune activation. These findings highlight the need to balance endosomal escape with timely mRNA release for functional expression. The system also overcame the mucus barrier and enabled mRNA transfection in ex vivo human lung tissue samples. After vibrating-mesh nebulization, it retained superior activity compared with lipid nanoparticles. These results support the PLGA/PBAE system as a viable platform for pulmonary mRNA vaccine delivery.
